The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of Molecular Endocrinology

• Publication date

  1993-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1677/JME.0.0110037PMID 8240670
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nuclear hormone receptors. Promiscuous liaisons.

  1993cited by this paper
• Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3.

  1992cited by this paper
• Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor.

  1992cited by this paper
• The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene.

  1992cited by this paper
• Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors

  1992cited by this paper
• Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid

  1992cited by this paper
• Chicken ovalbumin upstream promoter transcription factor (COUP-TF) dimers bind to different GGTCA response elements, allowing COUP-TF to repress hormonal induction of the vitamin D3, thyroid hormone, and retinoic acid receptors

  1992cited by this paper
• Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling

  1992cited by this paper
• Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

  1992cited by this paper
• Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently.

  1992cited by this paper
• 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor.

  1992cited by this paper
• 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα

  1992cited by this paper
• Receptor-mediated mechanisms of peroxisome proliferators.

  1992cited by this paper
• RXR alpha, a promiscuous partner of retinoic acid and thyroid hormone receptors.

  1992cited by this paper
• Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors.

  1992cited by this paper
• Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase.

  1992cited by this paper
• The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid.

  1992cited by this paper
• Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids.

  1992cited by this paper
• H‐2RIIBP (RXR beta) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes.

  1992cited by this paper
• Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells

  1992cited by this paper
• RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements.

  1991cited by this paper
• A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR.

  1991cited by this paper
• Interaction of LY171883 and other peroxisome proliferators with fatty-acid-binding protein isolated from rat liver.

  1991cited by this paper
• Thyromimetic effect of peroxisomal proliferators in rat liver.

  1991cited by this paper
• Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors.

  1991cited by this paper
• Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily

  1991cited by this paper
• Metabolic aspects of peroxisomal beta-oxidation.

  1991cited by this paper
• Specificity of a retinoic acid response element in the phosphoenolpyruvate carboxykinase gene promoter: consequences of both retinoic acid and thyroid hormone receptor binding.

  1991cited by this paper
• Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

  1990cited by this paper
• Clofibrate-inducible rat hepatic P450s IVA1 and IVA3 catalyze the omega- and (omega-1)-hydroxylation of fatty acids and the omega-hydroxylation of prostaglandins E1 and F2 alpha.

  1990cited by this paper
• Nuclear receptor that identifies a novel retinoic acid response pathway

  1990cited by this paper
• Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily.

  1990cited by this paper
• Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element

  1989cited by this paper
• The hypolipidemic effects of gemfibrozil in type V hyperlipidemia. A double-blind, crossover study.

  1989cited by this paper
• A versatile in vivo and in vitro eukaryotic expression vector for protein engineering

  1988cited by this paper
• Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.

  1988cited by this paper
• Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid omega-hydroxylase (cytochrome P-450LA omega). Identification of a new cytochrome P-450 gene family.

  1987cited by this paper
• Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators.

  1986cited by this paper
• Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans.

  1983cited by this paper
• The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid.

  1982cited by this paper
• A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug.

  1976cited by this paper
• Modification of Metabolism and Distribution of Lipids by Ethyl Chlorophenoxyisobutyrate

  1962cited by this paper

• Retinoic Acid Signaling & Metabolism in Heart Failure.

  2025cites this paper
• Identification of lipid metabolism-related genes in myocardial infarction: implications for diagnosis and therapy

  2025cites this paper
• Binding of Per- and Polyfluoroalkyl Substances (PFAS) to the PPARγ/RXRα-DNA Complex

  2023cites this paper
• PPARα alleviates inflammation via inhibiting NF-κB/Rel pathway in Vibrio splendidus challenged Apostichopus japonicus.

  2023cites this paper
• Auraptene, a citrus peel-derived natural product, prevents myocardial infarction-induced heart failure by activating PPARα in rats.

  2022cites this paper
• PPARα agonist WY-14,643 induces the PLA2/COX-2/ACOX1 pathway to enhance peroxisomal lipid metabolism and ameliorate alcoholic fatty liver in mice.

  2022cites this paper
• Potential link between microRNA-208 and cardiovascular diseases

  2021cites this paper
• Overcompensation of CoA Trapping by Di(2-ethylhexyl) Phthalate (DEHP) Metabolites in Livers of Wistar Rats

  2021cites this paper
• PPARs as Metabolic Sensors and Therapeutic Targets in Liver Diseases

  2021cites this paper
• The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics.

  2021cites this paper
• The biology of nutrients: genetic and molecular principles

  2021cites this paper
• PPARA/RXRA signalling regulates the fate of hepatic non-esterified fatty acids in a sheep model of maternal undernutrition.

  2020cites this paper
• Roles of peroxisome proliferator-activated receptor α in the pathogenesis of ethanol-induced liver disease.

  2020cites this paper
• Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases

  2020cites this paper
• Structural development of 1H-pyrazolo-[3,4-b]pyridine-4-carboxylic acid derivatives as human peroxisome proliferator-activated receptor alpha (PPARα)-selective agonists.

  2019cites this paper
• Characterization of Peroxisomal Regulation Networks.

  2018cites this paper
• Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis

  2018cites this paper
• Molecular mechanisms of tributyltin‐induced alterations in cholesterol homeostasis and steroidogenesis in hamster testis: In vivo and in vitro studies

  2018cites this paper
• The Nuclear Receptor PPAR&ggr; Controls Progressive Macrophage Polarization as a Ligand‐Insensitive Epigenomic Ratchet of Transcriptional Memory

  2018cites this paper
• Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARa , b/d, and g

  2018cites this paper
• Human Resistin Regulates Immunity to Helminths and Sepsis

  2017cites this paper
• Structural Requirement of PPARα Agonist Through QSARs and Molecular Simulation Analyses

  2017cites this paper
• Molecular effects of leptin on peroxisome proliferator activated receptor gamma (PPAR-γ) mRNA expression in rat's adipose and liver tissue.

  2017cites this paper
• Effect of DanQi Pill on PPARα, lipid disorders and arachidonic acid pathway in rat model of coronary heart disease

  2016cites this paper
• Therapeutic Role of Peroxisome Proliferator-Activated Receptors Gamma in the Treatment of Fibrosis

  2016cites this paper
• Network Analysis of Metabolite GWAS Hits: Implication of CPS1 and the Urea Cycle in Weight Maintenance

  2016cites this paper
• Monitoring Solution Structures of Peroxisome Proliferator-Activated Receptor β/δ upon Ligand Binding

  2016cites this paper
• Fibrate Acids and Esters for the Treatment of Hyperlipidemia (PPARα Activators)

  2016cites this paper
• Omega-3 Fatty Acids in Modern Parenteral Nutrition: A Review of the Current Evidence

  2016cites this paper
• Danqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway

  2015cites this paper
• Early investigational drugs targeting PPAR-α for the treatment of metabolic disease

  2015cites this paper
• Transcriptional Factors Mediating Retinoic Acid Signals in the Control of Energy Metabolism

  2015cites this paper
• Génétique, acides gras oméga-3 et facteurs de risque des maladies cardiovasculaires

  2015cites this paper
• Isolation of the molecular species of monogalactosyldiacylglycerols from brown edible seaweed Sargassum horneri and their inhibitory effects on triglyceride accumulation in 3T3-L1 adipocytes.

  2014cites this paper
• CCR5 Controls Immune and Metabolic Functions during Toxoplasma gondii Infection

  2014cites this paper
• Treatment of experimental autoimmune uveoretinitis with peroxisome proliferator-activated receptor α agonist fenofibrate

  2014cites this paper
• CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal models

  2014cites this paper
• PPAR Gamma at the Crossroads of Health and Disease: A Masterchef in Metabolic Homeostasis

  2014cites this paper
• Identification of novel multitargeted PPAR α / γ / δ pan agonists by core hopping of rosiglitazone

  2014cites this paper
• Estrès del reticle endoplasmàtic, inflamació i resistència a la insulina en cèl•lules musculars esquelètiques

  2014cites this paper
• Physiological functions of peroxisome proliferator-activated receptor β.

  2014cites this paper
• A Moderate Zinc Deficiency Does Not Impair Gene Expression of PPARα, PPARγ, and Mitochondrial Enoyl-CoA Delta Isomerase in the Liver of Growing Rats

  2014cites this paper
• Energy metabolism and cytochrome oxidase activity: linking metabolism to gene expression1

  2014cites this paper
• Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazone

  2014cites this paper
• Identification of novel multitargeted PPAR α / γ / δ pan agonists by core hopping of rosiglitazone

  2014cites this paper
• Fatty Acid Synthase Inhibition Induces Differential Expression of Genes Involved in Apoptosis and Cell Proliferation in Ocular Cancer Cells

  2013cites this paper
• Oxidative stress and apoptosis in a pig model of brain death (BD) and living donation (LD)

  2013cites this paper
• corepressors.with ligands, coactivators, and the interactions of retinoid X receptor control and retinoic acid receptors differentially Peroxisome proliferator-activated receptors

  2013cites this paper
• Multi-conformation dynamic pharmacophore modeling of the peroxisome proliferator-activated receptor γ for the discovery of novel agonists.

  2013cites this paper
• Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics

  2013cites this paper
• Alternatively Activated Macrophages Revisited: New Insights into the Regulation of Immunity, Inflammation and Metabolic Function following Parasite Infection.

  2013cites this paper
• EVALUATING THE ROLE OF PEROXISOME PROLIFERATOR- ACTIVATED RECEPTOR GAMA COACTIVATOR-1 ALPHA IN MITOCHONDRIAL BIOGENESIS IN GOLDFISH

  2013cites this paper
• Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics

  2013cites this paper
• X-linked Adrenoleukodystrophy

  2013cites this paper
• Inhibitors of Fatty Acid Synthesis Induce PPARα-Regulated Fatty Acid β-Oxidative Genes: Synergistic Roles of L-FABP and Glucose

  2013cites this paper
• Monitoring conformational changes in peroxisome proliferator-activated receptor α by a genetically encoded photoamino acid, cross-linking, and mass spectrometry.

  2013cites this paper
• ulti-conformation dynamic pharmacophore modeling of the eroxisome proliferator-activated receptor for the discovery of ovel agonists

  2013cites this paper
• Perspective on the Discovery and Scientific Impact of p38 MAP Kinase

  2013cites this paper
• Perilipin-2-null mice are protected against diet-induced obesity, adipose inflammation, and fatty liver disease[S]

  2013cites this paper
• Analyzing PPARα/ligand interactions by chemical cross-linking and high-resolution mass spectrometry.

  2013cites this paper
• Optimierung der Therapie des metastasierten Mammakarzinoms unter besonderer Berücksichtigung des Pi3K/Akt/mTOR-Signaltransduktionswegs

  2013cites this paper
• Massively parallel decoding of mammalian regulatory sequences supports a flexible organizational model

  2013cites this paper
• Modulation of TH1 differentiation Peroxisome Proliferator–Activated Receptorα–Independent Manner

  2012cites this paper
• Contribution différentielle du tissu adipeux mâle et femelle dans l’établissement du diabète de type 2 et des altérations cardiovasculaires : rôle de l’apport lipidique

  2012cites this paper
• Lipaemia, Inflammation and Atherosclerosis: Novel Opportunities in the Understanding and Treatment of Atherosclerosis

  2012cites this paper
• The Interaction of Environmentally Relevant Pollutants with Nuclear Hormone Receptors of European Flounder (Platichthys flesus)

  2012cites this paper
• Design Novel Dual Agonists for Treating Type-2 Diabetes by Targeting Peroxisome Proliferator-Activated Receptors with Core Hopping Approach

  2012cites this paper
• The role of neuronal peroxisome proliferator-activated receptor delta in diet-induced obesity and hypothalamic inflammation

  2012cites this paper
• Peroxisome proliferator-activated receptor-α agonists modulate CXCL9 and CXCL11 chemokines in Graves’ ophthalmopathy fibroblasts and preadipocytes

  2012cites this paper
• The Impact of Macrophage Membrane Lipid Composition on Innate Immune Response Mechanisms

  2012cites this paper
• Chemical cross-linking and high-resolution mass spectrometry to study protein-drug interactions.

  2012cites this paper
• IRF3 is a Critical Regulator of Adipose Glucose and Energy Homeostasis

  2012cites this paper
• Phytoceramide and sphingoid bases derived from brewer's yeast Saccharomyces pastorianus activate peroxisome proliferator-activated receptors

  2011cites this paper
• Biogenesis of peroxisomes in mammalian cells: Characterization of the Pex11 proteins and their role in peroxisomal growth and division

  2011cites this paper
• Electrophilic PPARγ Ligands Attenuate IL-1β and Silica-Induced Inflammatory Mediator Production in Human Lung Fibroblasts via a PPARγ-Independent Mechanism

  2011cites this paper
• The effects of high-dose fish oil supplementation during early infancy on neurodevelopment and language

  2011cites this paper
• Structure-based design, synthesis, and nonalcoholic steatohepatitis (NASH)-preventive effect of phenylpropanoic acid peroxisome proliferator-activated receptor (PPAR) α-selective agonists.

  2011cites this paper
• Tributyltin is a potent inhibitor of piscine peroxisome proliferator-activated receptor α and β.

  2011cites this paper
• Peroxisome proliferator‐activated receptor‐α agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function

  2011cites this paper
• Pharmacophore Identification for Peroxisome Proliferator-Activated Receptor Gamma Agonists

  2011cites this paper
• Peroxisome ProliferatorActivated Receptors (PPAR S): A Target with a Broad Therapeutic Potential for Human Diseases: An Overview

  2011cites this paper
• Dégradation des membres de la famille du LDLRpar la convertase PCSK9 : troisième locus de l'hypercholestérolémie familiale

  2011cites this paper
• Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.

  2010cites this paper
• Regulatory activity of polyunsaturated fatty acids in T-cell signaling.

  2010cites this paper
• Chlamydia pneumoniae disturbs cholesterol homeostasis in human THP-1 macrophages via JNK-PPARγ dependent signal transduction pathways.

  2010cites this paper
• Endocrine disruption induced by triorganotin (IV) compounds: Impacts in the reproductive and genetic function

  2010cites this paper
• PPAR receptor activation: Experimental studies on cardiac structure and function.

  2010cites this paper
• Papel de CCR5 na infecção oral por Toxoplasma gondii

  2010cites this paper
• Nuclear Hormone Receptor Medicinal Chemistry

  2010cites this paper
• Mediator Subunit Gal11p/MED15 Is Required for Fatty Acid-dependent Gene Activation by Yeast Transcription Factor Oaf1p*

  2009cites this paper
• PPARalpha ligand WY14643 reduced acute rejection after rat lung transplantation with the upregulation of IL-4, IL-10 and TGFbeta mRNA expression.

  2009cites this paper
• Human health risk assessment for peroxisome proliferators: more than 30 years of research.

  2009cites this paper
• Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation.

  2009cites this paper
• Interações dos receptores nucleares com seus ligantes: Estudos estruturais do receptor de hormônio tireoidiano, do receptor de mineralocorticóide e do receptor ativado por proliferadores peroxissomais

  2009cites this paper
• Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury.

  2009cites this paper
• Comparative LC Enantioseparation of Novel PPAR Agonists on Cellulose- and Amylose-Based Chiral Stationary Phases

  2009cites this paper
• Docosahexaenoic acid modulates the expression of T-bet and GATA-3 transcription factors, independently of PPARalpha, through suppression of MAP kinase activation.

  2009cites this paper
• Structure-dependent activation of peroxisome proliferator-activated receptor (PPAR) gamma by organotin compounds.

  2009cites this paper
• Lipids and Neurodevelopment

  2009cites this paper
• Transcriptional Modulation of the Immune Response by Peroxisome Proliferator-Activated Receptor-α Agonists in Autoimmune Disease1

  2009cites this paper